Detalhe da pesquisa
1.
Poorer survival outcomes in patients with multiple versus single primary melanoma.
Cancer
; 128(11): 2098-2106, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35319783
2.
Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells.
J Biol Chem
; 295(46): 15636-15649, 2020 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32883810
3.
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy.
Mol Cancer
; 20(1): 171, 2021 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34930302
4.
CD40 Cross-Linking Induces Migration of Renal Tumor Cell through Nuclear Factor of Activated T Cells (NFAT) Activation.
Int J Mol Sci
; 22(16)2021 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34445576
5.
Tumor-derived exosomes promote carcinogenesis of murine oral squamous cell carcinoma.
Carcinogenesis
; 41(5): 625-633, 2020 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31245809
6.
IL-36 Signaling in the Tumor Microenvironment.
Adv Exp Med Biol
; 1240: 95-110, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32060891
7.
Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer.
Cancer Immunol Immunother
; 68(1): 109-120, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30315348
8.
Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma.
Cancer Immunol Immunother
; 68(7): 1133-1141, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31139925
9.
Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunity.
J Immunol
; 194(12): 5937-47, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25972487
10.
Immunotherapeutic Targeting of Tumor-Associated Blood Vessels.
Adv Exp Med Biol
; 1036: 191-211, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29275473
11.
Tumor-associated mesenchymal stem cells inhibit naïve T cell expansion by blocking cysteine export from dendritic cells.
Int J Cancer
; 139(9): 2068-81, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27405489
12.
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction.
J Transl Med
; 14: 84, 2016 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27063186
13.
Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12.
Blood
; 121(15): 2923-33, 2013 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23365459
14.
Tumor-derived vascular pericytes anergize Th cells.
J Immunol
; 191(2): 971-81, 2013 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23785117
15.
Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice.
J Immunol
; 188(4): 1782-8, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22246626
16.
DLK1: a novel target for immunotherapeutic remodeling of the tumor blood vasculature.
Mol Ther
; 21(10): 1958-68, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23896726
17.
Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonists.
Front Immunol
; 15: 1334769, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38312842
18.
Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivo.
Mol Ther
; 20(3): 644-51, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22215017
19.
NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells.
Res Sq
; 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37886562
20.
Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes.
Front Immunol
; 14: 1171978, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37435077